Shares of Sorrento Therapeutics slid by a staggering 13.65% to $11.07 at 14:27 EST on Tuesday, following last session’s downward trend. NASDAQ Composite is dropping 1.65% to $13,309.70, following last session’s downward trend, This seems, up to now, an all-around negative trend exchanging session today.
Sorrento Therapeutics’s last close was $12.82, 75.16% under its 52-week high of $19.39.
Sorrento Therapeutics’s Sales
Sorrento Therapeutics’s sales growth is 166.3% for the ongoing quarter and 173.3% for the next. The company’s growth estimates for the ongoing quarter and the next is 200% and 230.6%, respectively.
Sorrento Therapeutics’s Revenue
Year-on-year quarterly revenue growth declined by 11.7%, now sitting on 39.99M for the twelve trailing months.
Volatility
Sorrento Therapeutics’s last day, last week, and last month’s average volatility was 2.57%, 3.45%, and 7.99%, respectively.
Sorrento Therapeutics’s last day, last week, and last month’s high and low average amplitude percentage was 10.03%, 7.72%, and 13.50%, respectively.
Sorrento Therapeutics’s Stock Yearly Top and Bottom Value
Sorrento Therapeutics’s stock is valued at $11.07 at 14:27 EST, way below its 52-week high of $19.39 and way above its 52-week low of $1.55.
Sorrento Therapeutics’s Moving Average
Sorrento Therapeutics’s worth is under its 50-day moving average of $11.44 and way above its 200-day moving average of $9.35.
